As recommended by the Malaria Eradication (MalERA) Consultative Group on Modelling, there is a need to understand better the effects of seasonality on malaria morbidity.
Discipline-specific Malaria Eradication Research Agenda (malERA) Consultative Groups have recognized several cross-cutting issues that must be addressed to prevent repetition of some of the mistakes of past malaria elimination campaigns in future programs.
Encouraged by the early success of using dichloro-diphenyl-trichloroethane (DDT) against malaria, the World Health Organization (WHO) embarked on the Global Malaria Eradication Program (GMEP) in 1955.
Malaria modeling can inform policy and guide research for malaria elimination and eradication from local implementation to global policy.
Health systems research and development is needed to support the global malaria eradication agenda.
Many of malaria's signs and symptoms are indistinguishable from those of other febrile diseases.
Different challenges are presented by the variety of malaria transmission environments present in the world today.
Vaccines could be a crucial component of efforts to eradicate malaria.
The interruption of malaria transmission worldwide is one of the greatest challenges for international health and development communities.
Despite being one of the most prevalent tropical diseases, for many years malaria was not a commercial priority for the pharmaceutical industry.